Testosterone therapy for women with poor ovarian response undergoing IVF: a meta-analysis of randomized controlled trials
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Purpose The aim of the present systematic review and meta-analysis was to summarize evidence on the effectiveness of testosterone supplementation for poor ovarian responders (POR) on IVF outcomes. The primary outcome was live birth rate (LBR); secondary outcomes were clinical pregnancy rate (CPR), miscarriage rate (MR), total and MII oocytes, and total embryos.Methods This meta-analysis of randomized controlled trials (RCTs) evaluates the effects of testosterone administration before/during COS compared with a control group in patients defined as POR. The primary outcome was live birth rate (LBR); secondary outcomes were clinical pregnancy rate (CPR), miscarriage rate (MR), total and MII oocytes, and total embryos. Pooled results were expressed as risk ratio (RR) or mean differences (MD) with 95% confidence interval (95% CI). Sources of heterogeneity were investigated through sensitivity and subgroup analysis. All analyses were performed by using the random-effects model.Results Women receiving testosterone showed higher LBR (RR 2.29, 95% CI 1.31-4.01, p = 0.004), CPR (RR 2.32, 95% CI 1.47-3.64, p = 0.0003), total oocytes (MD = 1.28 [95% CI 0.83, 1.73], p < 0.00001), MII oocytes (MD = 0.96 [95% CI 0.28, 1.65], p = 0.006), and total embryos (MD = 1.17 [95% CI 0.67, 1.67], p < 0.00001) in comparison to controls, with no difference in MR (p = ns). Sensitivity and subgroup analysis did not provide statistical changes to the pooled results.Conclusions Testosterone therapy seems promising to improve the success at IVF in POR patients. Further RCTs with rigorous methodology and inclusion criteria are still mandatory.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Moreover, by a recent meta-analysis, testosterone therapy increased IVF success in women with a poor response to ovarian stimulation.84”
From Prenatal Origins of Endometriosis Pathology and Pain: Reviewing the Evidence of a Role for Low Testosterone (2023) · cites this paper as [84]
The cited source says what the claim attributes to it.
In the citing paper
“Furthermore, giving testosterone to poor gonadotropin responders (who overlap with endometriosis in having low LH to FSH and short AGDs) increases retrieved oocytes and improves IVF success (Bosdou et al., 2012; Luo et al., 2014; Noventa et al., 2019; but not in Sunkara et al., 2011).”
From Endometriosis and polycystic ovary syndrome are diametric disorders (2021) · cites this paper as Noventa et al., 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,657
Androgen Levels in Adult Females: Changes with Age, Menopause, and Oophorectomy
Davison, S. L., Bell, R., Donath, S., Montalto, J. G., & Davis, S. R. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0212 · Cited by 998
Androgen and follicle stimulating hormone interactions in primate ovarian follicle development
Weil, S., Vendola, K., Zhou, J., & Bondy, C. A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5929 · Cited by 592
Lambalk, C. B., Banga, F. R., Huirne, J. A., Toftager, M., Pinborg, A., Homburg, R., van der Veen, F., & van Wely, M. (2017) · Human Reproduction Update · doi:10.1093/humupd/dmx017 · Cited by 404
Weil, S. J., Vendola, K., Zhou, J., Adesanya, O. O., Wang, J., Okafor, J., & Bondy, C. A. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.7.4917 · Cited by 359
Vendola, K., Zhou, J., Wang, J., Famuyiwa, O. A., Bievre, M., & Bondy, C. A. (1999) · Biology of Reproduction · doi:10.1095/biolreprod61.2.353 · Cited by 324
Research works printed but not linked: 1
- Singh M, Singh R, Jindal A, Jindal PC. A prospective randomized controlled study depicting favourable IVF outcomes of pretreatment with transdermal-testosterone in poorresponders undergoing ART cycles. Human Reproduction. 2016;31(Issue suppl_1):i1–i513.
Cited by
Androgens and ovarian function: translation from basic discovery research to clinical impact
Walters, K. A., Rodriguez Paris, V, Aflatounian, A., & Handelsman, D. J. (2019) · Journal of Endocrinology · doi:10.1530/joe-19-0096 · Cited by 104
Endometriosis and polycystic ovary syndrome are diametric disorders
Dinsdale, N. L., & Crespi, B. J. (2021) · Evolutionary Applications · doi:10.1111/eva.13244 · Cited by 90
“Furthermore, giving testosterone to poor gonadotropin responders (who overlap with endometriosis in having low LH to FSH and short AGDs) increases retrieved oocytes and improves IVF success (Bosdou et al., 2012; Luo et al., 2014; Noventa et al., 2019; but not in Sunkara et al., 2011).”
BackgroundVitagliano, A., Laganà, A. S., de Ziegler, D., Cicinelli, R., Santarsiero, C. M., Buzzaccarini, G., Chiàntera, V., Cicinelli, E., & Marinaccio, M. (2022) · Diagnostics · doi:10.3390/diagnostics12092250 · Cited by 88
Self-citationCozzolino, M., Cecchino, G. N., Troiano, G., & Romanelli, C. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2020.03.007 · Cited by 58
Self-citationWhat Is the Best Regimen for Ovarian Stimulation of Poor Responders in ART/IVF?
Blumenfeld, Z. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00192 · Cited by 56
“Most recently, a metaanalysis of RCT using testosterone cotreatment in POR patients found that adding testosterone to COS has significantly increased the number of retrieved oocytes, number of generated embrya, clinical PR, and LBR in comparison to controls (32).”
Background
Metadata
- Authors
- Noventa, M., Vitagliano, A., Andrisani, A., Blaganje, M., Viganò, P., Papaelo, E., Scioscia, M., Cavallin, F., Ambrosini, G., & Cozzolino, M.
- Affiliations
- University of Padua (IT)
- Ljubljana University Medical Centre (SI)
- IRCCS Ospedale San Raffaele (IT)
- Policlinico Abano Terme (IT)
- Universidad Rey Juan Carlos (ES)
- Corresponding author
- Noventa, Marco
- ORCID
- Venue
- Journal of Assisted Reproduction and Genetics
- Published
- 2019-01-05
- Volume
- 36
- Issue
- 4
- Pages
- 673-683
- ISSN
- 0740-7769 (ISSN-L)
- 1058-0468
- 1573-7330
- PMC
- PMC6505000
- OpenAlex
- W2907176017
- Cited by
- 59
- References
- 56
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 4 · 2023: 10 · 2022: 12 · 2021: 10 · 2020: 7 · 2019: 4
- FWCI
- 1.16
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Assisted Reproduction and Genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
- Keywords
- testosterone supplementation, poor ovarian response, in vitro fertilization, live birth rate, clinical pregnancy rate, miscarriage rate, oocyte yield, metaphase II oocytes, embryo yield, controlled ovarian stimulation, female infertility
- MeSH terms
- Abortion, Spontaneous, Birth Rate, Female, Fertilization in Vitro, Humans, Infertility, Female, Oocytes, Ovulation Induction, Pregnancy, Pregnancy Outcome, Testosterone, Randomized Controlled Trials as Topic, Pregnancy Rate, Live Birth, Anti-Mullerian Hormone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Testosterone therapy for women with poor ovarian response undergoing IVF: a meta-analysis of randomized controlled trials. https://app.cochat.ai/papers/10.1007/s10815-018-1383-2
- The paper
- Noventa, M., Vitagliano, A., Andrisani, A., Blaganje, M., Viganò, P., Papaelo, E., Scioscia, M., Cavallin, F., Ambrosini, G., & Cozzolino, M. (2019). Testosterone therapy for women with poor ovarian response undergoing IVF: a meta-analysis of randomized controlled trials. Journal of Assisted Reproduction and Genetics. https://doi.org/10.1007/s10815-018-1383-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.